Of clinical importance, our data demonstrated that the presence of CD4+PD-1+CXCL13+ T cells was associated with poor treatment outcome in LR-CHL, suggesting an important role of CD4+PD-1+CXCL13+ T cells in treatment response. The gene discussed is PDCD1; the disease is classic Hodgkin lymphoma.